Tobii’s industry-leading eye-tracking technology will be utilized to provide innovative gaze-directed interface for ControlRad’s radiation reduction solutions.

PHILADELPHIA, PA – October. 30, 2018 – ControlRad, Inc., a medical technology company focused on dramatically reducing unnecessary radiation exposure to patients and physicians during fluoroscopic procedures, announced today a partnership with Stockholm-based Tobii AB, the world leader in eye-tracking technology. Tobii will be the exclusive source of ControlRad’s eye-tracker interface for its solution that provides up to 75% radiation reduction technology without reducing image quality or impacting provider workflow.


Latest News

Infographic (download)

Infographic for download